Shingo Inaguma

Professor

Nagoya University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Shingo Inaguma is a Professor at Nagoya City University in Japan. His research primarily focuses on cancer biology, particularly in colorectal cancer, pleural mesothelioma, and sinonasal tract melanoma. His recent publications investigate the prognostic implications of various biomarkers and signaling pathways in cancer progression and treatment outcomes. Professor Inaguma's work includes examining the roles of tumor microenvironment factors and immune evasion mechanisms in various malignancies.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Medical University of Gdansk

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shingo Inaguma

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Simultaneous Expression of CD70 and POSTN in Cancer-Associated Fibroblasts Predicts Worse Survival of Colorectal Cancer Patients

Stromal POSTN Enhances Motility of Both Cancer and Stromal Cells and Predicts Poor Survival in Colorectal Cancer

CD70 and PD-L1 (CD274) co-expression predicts poor clinical outcomes in patients with pleural mesothelioma.

SPATA18 Expression Predicts Favorable Clinical Outcome in Colorectal Cancer

The Complete Loss of p53 Expression Uniquely Predicts Worse Prognosis in Colorectal Cancer

Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature.

The Risk Analyses of Lymph Node Metastasis and Recurrence for Submucosal Invasive Colorectal Cancer: Novel Criteria to Skip Completion Surgery

Determining Infected Aortic Aneurysm Treatment Using Focused Detection of Helicobacter cinaedi.

PBK Enhances Cellular Proliferation With Histone H3 Phosphorylation and Suppresses Migration and Invasion With CDH1 Stabilization in Colorectal Cancer.

Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model

Collaborators (7)

Emiko Rimbara

Toyonori Tsuzuki

Hiromi Kataoka

Satoru Takahashi

Toshinori Hyodo

Kazuhiro Nagao

Bartosz Wasąg

Make your next move.

Shingo Inaguma

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Simultaneous Expression of CD70 and POSTN in Cancer-Associated Fibroblasts Predicts Worse Survival of Colorectal Cancer Patients

Stromal POSTN Enhances Motility of Both Cancer and Stromal Cells and Predicts Poor Survival in Colorectal Cancer

CD70 and PD-L1 (CD274) co-expression predicts poor clinical outcomes in patients with pleural mesothelioma.

SPATA18 Expression Predicts Favorable Clinical Outcome in Colorectal Cancer

The Complete Loss of p53 Expression Uniquely Predicts Worse Prognosis in Colorectal Cancer

Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature.

The Risk Analyses of Lymph Node Metastasis and Recurrence for Submucosal Invasive Colorectal Cancer: Novel Criteria to Skip Completion Surgery

Determining Infected Aortic Aneurysm Treatment Using Focused Detection of Helicobacter cinaedi.

PBK Enhances Cellular Proliferation With Histone H3 Phosphorylation and Suppresses Migration and Invasion With CDH1 Stabilization in Colorectal Cancer.

Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-&kappa;B Signaling in a Rat Non-Alcoholic Steatohepatitis Model

Collaborators (7)

Emiko Rimbara

Toyonori Tsuzuki

Hiromi Kataoka

Satoru Takahashi

Toshinori Hyodo

Kazuhiro Nagao

Bartosz Wasąg

Make your next move.

Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model